228 related articles for article (PubMed ID: 11289128)
21. Topoisomerase II inhibitor-related acute myeloid leukaemia.
Pui CH; Relling MV
Br J Haematol; 2000 Apr; 109(1):13-23. PubMed ID: 10848777
[No Abstract] [Full Text] [Related]
22. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
[TBL] [Abstract][Full Text] [Related]
23. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
[TBL] [Abstract][Full Text] [Related]
24. Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment.
Jung R; Jacobs U; Krumbholz M; Langer T; Keller T; De Lorenzo P; Valsecchi MG; van der Velden VH; Moericke A; Stanulla M; Teigler-Schlegel A; Panzer-Gruemayer ER; van Dongen JJ; Schrappe M; den Boer ML; Pieters R; Rascher W; Metzler M
Leukemia; 2010 Apr; 24(4):903-7. PubMed ID: 20164851
[No Abstract] [Full Text] [Related]
25. Chemical exposure and infant leukaemia: development of an adverse outcome pathway (AOP) for aetiology and risk assessment research.
Pelkonen O; Terron A; Hernandez AF; Menendez P; Bennekou SH;
Arch Toxicol; 2017 Aug; 91(8):2763-2780. PubMed ID: 28536863
[TBL] [Abstract][Full Text] [Related]
26. Analysis of acute leukemias with MLL/ENL fusion transcripts: identification of two novel breakpoints in ENL.
Fu JF; Liang DC; Shih LY
Am J Clin Pathol; 2007 Jan; 127(1):24-30. PubMed ID: 17145626
[TBL] [Abstract][Full Text] [Related]
27. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors.
Aplan PD; Chervinsky DS; Stanulla M; Burhans WC
Blood; 1996 Apr; 87(7):2649-58. PubMed ID: 8639880
[TBL] [Abstract][Full Text] [Related]
28. The role of the MLL gene in infant leukemia.
Eguchi M; Eguchi-Ishimae M; Greaves M
Int J Hematol; 2003 Dec; 78(5):390-401. PubMed ID: 14704031
[TBL] [Abstract][Full Text] [Related]
29. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
[TBL] [Abstract][Full Text] [Related]
30. RAS mutations in pediatric leukemias with MLL gene rearrangements.
Mahgoub N; Parker RI; Hosler MR; Close P; Winick NJ; Masterson M; Shannon KM; Felix CA
Genes Chromosomes Cancer; 1998 Mar; 21(3):270-5. PubMed ID: 9523205
[TBL] [Abstract][Full Text] [Related]
31. 11q23 rearrangements in acute leukemia.
Rubnitz JE; Behm FG; Downing JR
Leukemia; 1996 Jan; 10(1):74-82. PubMed ID: 8558942
[TBL] [Abstract][Full Text] [Related]
32. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group.
Ross JA; Potter JD; Reaman GH; Pendergrass TW; Robison LL
Cancer Causes Control; 1996 Nov; 7(6):581-90. PubMed ID: 8932918
[TBL] [Abstract][Full Text] [Related]
33. Detection of MLL gene self-fusions by RT-PCR and automated fluorescent DNA-fragment analysis.
Forrest DL; Adomat SA; Nevill TJ; Barnett MJ; Growe G; Horsman DE
Cancer Genet Cytogenet; 1999 Jul; 112(2):181-3. PubMed ID: 10686950
[No Abstract] [Full Text] [Related]
34. Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings.
Watanabe N; Kobayashi H; Ichiji O; Yoshida MA; Kikuta A; Komada Y; Sekine I; Ishida Y; Horiukoshi Y; Tsunematsu Y; Yano M; Nakadate H; Kaneko Y
Leukemia; 2003 May; 17(5):876-82. PubMed ID: 12750700
[TBL] [Abstract][Full Text] [Related]
35. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.
Corral J; Forster A; Thompson S; Lampert F; Kaneko Y; Slater R; Kroes WG; van der Schoot CE; Ludwig WD; Karpas A
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8538-42. PubMed ID: 8378328
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of infant acute leukemia.
Hilden JM; Frestedt JL; Kersey JH
Leuk Lymphoma; 1997 Apr; 25(3-4):191-9. PubMed ID: 9168430
[TBL] [Abstract][Full Text] [Related]
37. Backtracking leukemia to birth.
Rowley JD
Nat Med; 1998 Feb; 4(2):150-1. PubMed ID: 9461182
[No Abstract] [Full Text] [Related]
38. Potential role for wild-type p53 in leukemias with MLL gene translocations.
Megonigal MD; Rappaport EF; Nowell PC; Lange BJ; Felix CA
Oncogene; 1998 Mar; 16(10):1351-6. PubMed ID: 9546437
[TBL] [Abstract][Full Text] [Related]
39. Effects of topoisomerase 2 inhibitors on the MLL gene in children receiving chemotherapy: a prospective study.
Ng A; Taylor GM; Wynn RF; Eden OB
Leukemia; 2005 Feb; 19(2):253-9. PubMed ID: 15592432
[TBL] [Abstract][Full Text] [Related]
40. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).
Taki T; Kano H; Taniwaki M; Sako M; Yanagisawa M; Hayashi Y
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14535-40. PubMed ID: 10588740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
